GlassScriptPhysician profile
James S Garber
NPI 1942434618
$783.78
in general payments reported to CMS, 2019-2025
20 companies · $310 in 2025
The $310 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.02 · 2022: $343 · 2023: $45.32 · 2024: $23.57 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aap Implants INC | $184.05 | 2021-2022 | |
| Nevro Corp. | $72.76 | 2022 | |
| Orthofix Medical, INC. | $64.17 | 2023-2025 | Physio-Stim, Spinal-Stim |
| Organogenesis INC. | $52.48 | 2021-2022 | |
| Stryker Corporation | $47.87 | 2025 | Ortholoc 2 Lapifuse |
| Fusion Orthopedics USA, LLC | $42.83 | 2025 | |
| Paratek Pharmaceuticals, INC. | $40.93 | 2025 | Nuzyra |
| Lilly USA, LLC | $36.81 | 2023-2025 | Mounjaro, Zepbound |
| Bioventus LLC | $35.60 | 2025 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $32.24 | 2025 | Motoband |
| In2bones USA, LLC | $31.80 | 2022 | |
| Amgen INC. | $20.89 | 2025 | Krystexxa |
| Biotissue Holdings INC. | $18.68 | 2021 | |
| Reprise Biomedical, INC. | $18.31 | 2025 | Miro3d |
| Abbott Laboratories | $17.73 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $16.06 | 2022 | |
| Kuros Biosciences USA, INC | $13.58 | 2025 | Magnetos |
| Orpyx Medical Technologies US INC. | $13.40 | 2023 | Orpyx Si |
| Advanced Oxygen Therapy INC. | $12.40 | 2025 | Topical Oxygen Chamber For Extremities |
| Alfasigma USA, INC. | $11.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Garber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.